PHARMARON: (1) PROPOSED ADOPTION OF THE 2023 A SHARE INCENTIVE SCHEME AND THE ASSESSMENT MANAGEMENT MEASURES; (2) PROPOSED ISSUE AND GRANT OF THE NEW A SHARES UNDER THE 2023 A SHARE INCENTIVE SCHEME; AND (3) PROPOSED AUTHORIZATION TO THE BOARD TO HANDLE MA

Hong Kong Stock Exchange · Mar 30, 2023 22:44

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

康龍化成：(1) 建議採納2023年A股激勵計劃及考核管理辦法；(2) 建議根據2023年A股激勵計劃發行及授出新A股；及(3) 建議授權董事會辦理2023年A股激勵計劃相關事宜

PHARMARON: (1) PROPOSED ADOPTION OF THE 2023 A SHARE INCENTIVE SCHEME AND THE ASSESSMENT MANAGEMENT MEASURES; (2) PROPOSED ISSUE AND GRANT OF THE NEW A SHARES UNDER THE 2023 A SHARE INCENTIVE SCHEME; AND (3) PROPOSED AUTHORIZATION TO THE BOARD TO HANDLE MA

Risk Disclaimer

Statement